Tissue factor pathway inhibitor is required for cerebrovascular development in mice
- 13 January 2021
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 137 (2), 258-268
- https://doi.org/10.1182/blood.2020006054
Abstract
Tissue factor pathway inhibitor (TFPI) inhibits proteases in the blood coagulation cascade that lead to the production of thrombin, including prothrombinase (factor Xa [FXa]/FVa), the catalytic complex that directly generates thrombin. Thus, TFPI and FV are directly linked in regulating the procoagulant response. Studies using knockout mice indicate that TFPI and FV are necessary for embryogenesis, but their contributions to vascular development are unclear. We performed extensive histological analyses of Tfpi(-/-) and Tfpi(-/-) F5(-/-) mouse embryos to investigate the importance of the interplay between TFPI and FV in regulating hemostasis and vascular development during embryogenesis. We observed normal tissue development throughout Tfpi(-/-) embryos, except in the central nervous system (CNS). The CNS displayed stunted brain growth, delayed development of the meninges, and severe vascular pathology characterized by the formation of glomeruloid bodies surrounding areas of cellular death, fibrin deposition, and hemorrhage. Removing FV from Tfpi(-/-) embryos completely ameliorated their brain pathology, suggesting that TFPI dampens FV-dependent procoagulant activity in a manner that modulates cerebrovascular development. Thus, we have identified a previously unrecognized role for TFPI activity within the CNS. This TFPI activity likely diminishes an effect of excess thrombin activity on signaling pathways that control cerebral vascular development.This publication has 57 references indexed in Scilit:
- The importance of microglia in the development of the vasculature in the central nervous systemVascular Cell, 2013
- Tissue Factor Pathway Inhibitor Blocks Angiogenesis via Its Carboxyl TerminusArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood–brain barrierProceedings of the National Academy of Sciences of the United States of America, 2011
- Wnt/β-catenin signaling is required for CNS, but not non-CNS, angiogenesisProceedings of the National Academy of Sciences of the United States of America, 2009
- Tissue factor pathway inhibitor‐γ is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humansJournal of Thrombosis and Haemostasis, 2008
- Regulation of tissue factor–induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1Blood, 2005
- The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasisBlood, 2003
- Tissue Factor Pathway Inhibitor Inhibits Endothelial Cell Proliferation via Association with the Very Low Density Lipoprotein ReceptorOnline Journal of Public Health Informatics, 2001
- Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficitJCI Insight, 1999
- Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor VNature, 1996